A proposed portfolio of 50 health-supplement products needed product-by-product readiness and submission control rather than a single launch assumption.
Trading reference only. Each product still needs the applicable classification and registration.
Activity 4721016 · Dubai mainland · DET reference
Includes reselling the supplements which are classified as food and not drugs and are intended to provide nutrients which might be lacked in the food or otherwise not be consumed in sufficient quantities, it involves vitamins, minerals, fiber, fatty acids, or amino acids, honey and herbal tonics, nourishing substitutes for athletes and diet recipes.
Find this activity in the directoryRead the requirement, the constraint and the proposed route together. The value of this case is the reasoning behind the setup, rather than an activity name in isolation.
Four phases, 9 checkpoints. See the route at a glance, then open a checkpoint for the work, owner and timing. Daily updates continue during active work.
Confirm the route and open your file.
Activity, legal form and Dubai mainland
Owner / You and VantablackNamed team, checklist and your project timeline
Owner / VantablackDocuments and activity checks.
Passports, KYC and anything the activity needs
Owner / You, checked by VantablackSubmitted to the Department of Economy and Tourism
Owner / Vantablack, then the authorityPremises and the licence decision.
Lease and Ejari for the dedicated premises
Owner / You and VantablackYour company exists; documents in your workspace
Owner / The authorityFollow-on work in your agreed scope.
Immigration file for you and your team
Owner / Vantablack PRO teamBank application, VAT and Corporate Tax registration
Owner / Vantablack and the bankList your services on the Ecosystem and receive requests
Owner / You, on VantablackTime markers are our service standards; authority steps follow the authority’s own timeline, and approvals are the authority’s decision. Your accepted quote confirms which post-licence services are included. Sales depend on licensing, approvals and demand.
Select a point to read the reasoning.
A proposed portfolio of 50 health-supplement products needed product-by-product readiness and submission control rather than a single launch assumption.
The client needed to register a portfolio described as 50 health-supplement products in Dubai. At that scale, one missing dossier or unresolved product claim could disrupt launch planning. The account does not establish how many products reached submission, registration or sale.
Use one readiness record per product and sequence submissions by evidence quality and regulatory status. Keep complete dossiers separate from products with label, formula or classification questions. Record each authority response and certificate rather than describing submission or planned certificate issuance as a completed registration.
Track product identifier, intended authority and classification, formula and dose review, artwork version, analysis report, Free Sale Certificate, missing evidence, submission date/reference, authority comments, response owner and certificate/status. This is a proposed project-control tool; it is not a reconstructed record of what happened to all 50 products.
DM’s guideline sets product dossier, labelling and claims requirements for supplements in its scope. Registration must precede Dubai market placement. Confirm the scope for each formula and presentation; do not assume shared branding makes one registration cover an entire range.
DM health-supplement guideline 29, sections 7–9 — checked 20 October 2026. Read the official publication.
Proposed approach: submit complete, correctly classified dossiers first; hold products with unresolved labels or claims; isolate borderline products for classification. EDE’s classification service determines whether its marketing-authorisation route applies. Case 60 illustrates the restricted-ingredient question that can affect a single item.
EDE: Classification of a Medical Product — checked 20 October 2026. Read the official publication.
No registered-product count, certificate list, actual timeline or cost is recorded. Budget by the confirmed authority and application scope, including possible testing or document work; no per-product tariff is asserted here. A portfolio launch needs traceable decisions and evidence for every product, not a promise that all items finish together.
Related investigation: Case 60.
Assess storage, distribution and any customer-facing premises against the actual activity and authority requirements.
Quote company and professional work separately from product dossiers or clinical approvals, premises, equipment and operating costs. No actual case budget or verified authority tariff is supplied here.
Planning guidance, not a statement of this client’s costs or completed approvals. Confirm the specific scope and quotation.
Classification follows what is actually done with patients or products. Corporate formation does not by itself authorise clinical treatment, a health facility or each product.
A clinical service, restricted ingredient, new treatment or additional product can introduce a separate regulatory path.
